John Ward

Title(s)Emeritus Professor, Radiology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #0610
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The Association of Peri-Prostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance. J Urol. 2020 Jul 27; 101097JU0000000000001321. Gregg JR, Surasi DS, Childs A, Moll N, Ward JF, Kim J, Daniel CR, Logothetis C, Bathala T, Davis JW. PMID: 32718204.
      View in: PubMed   Mentions:    Fields:    
    2. Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus. Eur Urol. 2020 Sep; 78(3):371-378. Lebastchi AH, George AK, Polascik TJ, Coleman J, de la Rosette J, Turkbey B, Wood BJ, Gorin MA, Sidana A, Ghai S, Tay KJ, Ward JF, Sanchez-Salas R, Muller BG, Malavaud B, Mozer P, Crouzet S, Choyke PL, Ukimura O, Rastinehad AR, Pinto PA. PMID: 32532513.
      View in: PubMed   Mentions:    Fields:    
    3. Comparing confirmatory biopsy outcomes between MRI-targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillance. BJU Int. 2020 May 01. Shapiro DD, Gregg JR, Lim AH, Nogueras-González GM, Choi H, Kang HC, Inguillo IA, Chapin BF, Davis JW, Ward JF. PMID: 32357283.
      View in: PubMed   Mentions:    Fields:    
    4. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology. 2020 Jul; 296(1):76-84. Westphalen AC, McCulloch CE, Anaokar JM, Arora S, Barashi NS, Barentsz JO, Bathala TK, Bittencourt LK, Booker MT, Braxton VG, Carroll PR, Casalino DD, Chang SD, Coakley FV, Dhatt R, Eberhardt SC, Foster BR, Froemming AT, Fütterer JJ, Ganeshan DM, Gertner MR, Mankowski Gettle L, Ghai S, Gupta RT, Hahn ME, Houshyar R, Kim C, Kim CK, Lall C, Margolis DJA, McRae SE, Oto A, Parsons RB, Patel NU, Pinto PA, Polascik TJ, Spilseth B, Starcevich JB, Tammisetti VS, Taneja SS, Turkbey B, Verma S, Ward JF, Warlick CA, Weinberger AR, Yu J, Zagoria RJ, Rosenkrantz AB. PMID: 32315265.
      View in: PubMed   Mentions:    Fields:    
    5. Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort. Urology. 2020 Apr; 138:91-97. Gregg JR, Davis JW, Reichard C, Wang X, Achim M, Chapin BF, Pisters L, Pettaway C, Ward JF, Choi S, Nguyen QN, Kuban D, Babaian R, Troncoso P, Madsen LT, Logothetis C, Kim J. PMID: 31899230.
      View in: PubMed   Mentions:    Fields:    
    6. Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer. Eur Urol Oncol. 2019 Mar 29. Li R, Duplisea JJ, Petros FG, González GMN, Tu SM, Karam JA, Huynh TT, Ward JF. PMID: 31412007.
      View in: PubMed   Mentions: 1     Fields:    
    7. Detection and Treatment of Primary Prostatic Melanoma. Urology. 2019 01; 123:16-19. Li R, Zhang M, Duplisea JJ, Troncoso P, Ward JF. PMID: 30195014.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research. Prostate Cancer Prostatic Dis. 2018 11; 21(4):524-532. Altok M, Kim B, Patel BB, Shih YT, Ward JF, McRae SE, Chapin BF, Pisters LL, Pettaway CA, Kim J, Demirel HC, Davis JW. PMID: 29988098.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life Outcomes. Eur Urol. 2018 08; 74(2):140-143. Reichard CA, Gregg JR, Achim MF, Aparicio AM, Pettaway CA, Pisters LL, Ward JF, Davis JW, Chapin BF. PMID: 29656854.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU Int. 2018 04; 121(4):540-548. Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA. PMID: 28941030.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Characterization of Glomus Tumors of the Kidney. Clin Genitourin Cancer. 2017 Sep 07. Li R, Petros FG, Davis CJ, Ward JF. PMID: 28967505.
      View in: PubMed   Mentions:    Fields:    
    12. Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer. BJU Int. 2018 01; 121(1):69-76. Basourakos SP, Davis JW, Chapin BF, Ward JF, Pettaway CA, Pisters LL, Navai N, Achim MF, Wang X, Chen HC, Choi S, Kuban D, Troncoso P, Hanash S, Thompson TC, Kim J. PMID: 28710901.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Salvage prostatectomy for post-radiation adenocarcinoma with treatment effect: Pathological and oncological outcomes. Can Urol Assoc J. 2017 Jul; 11(7):E277-E284. Metcalfe MJ, Troncoso P, Guo CC, Chen HC, Bozkurt Y, Ward JF, Pisters LL. PMID: 28761588.
      View in: PubMed   Mentions:
    14. VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer. Nat Med. 2017 May; 23(5):551-555. Gao J, Ward JF, Pettaway CA, Shi LZ, Subudhi SK, Vence LM, Zhao H, Chen J, Chen H, Efstathiou E, Troncoso P, Allison JP, Logothetis CJ, Wistuba II, Sepulveda MA, Sun J, Wargo J, Blando J, Sharma P. PMID: 28346412.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimalsCells
    15. Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients. BJU Int. 2017 06; 119(6):896-904. Crouzet S, Blana A, Murat FJ, Pasticier G, Brown SCW, Conti GN, Ganzer R, Chapet O, Gelet A, Chaussy CG, Robertson CN, Thuroff S, Ward JF. PMID: 28063191.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis. Oncotarget. 2016 Dec 27; 7(52):86280-86289. Bilen MA, Hess KR, Campbell MT, Wang J, Broaddus RR, Karam JA, Ward JF, Wood CG, Choi SL, Rao P, Zhang M, Naing A, General R, Cauley DH, Lin SH, Logothetis CJ, Pisters LL, Tu SM. PMID: 27861143.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy. Can J Urol. 2016 Jun; 23(3):8271-7. Kenney PA, Nawaf CB, Mustafa M, Wen S, Wszolek MF, Pettaway CA, Ward JF, Davis JW, Pisters LL. PMID: 27347619.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer. Eur Urol. 2017 03; 71(3):476-482. Pearce SM, Golan S, Gorin MA, Luckenbaugh AN, Williams SB, Ward JF, Montgomery JS, Hafez KS, Weizer AZ, Pierorazio PM, Allaf ME, Eggener SE. PMID: 27234998.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    19. Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer. EBioMedicine. 2016 May; 7:85-93. Kim J, Davis JW, Klein EA, Magi-Galluzzi C, Lotan Y, Ward JF, Pisters LL, Basler JW, Pettaway CA, Stephenson A, Li Ning Tapia EM, Efstathiou E, Wang X, Do KA, Lee JJ, Gorlov IP, Vornik LA, Hoque AM, Prokhorova IN, Parnes HL, Lippman SM, Thompson IM, Brown PH, Logothetis CJ, Troncoso P. PMID: 27322462.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer. Cancer. 2016 06 15; 122(12):1836-43. Tu SM, Bilen MA, Hess KR, Broaddus RR, Kopetz S, Wei C, Pagliaro LC, Karam JA, Ward JF, Wood CG, Rao P, Tu ZH, General R, Chen AH, Nieto YL, Yeung SC, Lin SH, Logothetis CJ, Pisters LL. PMID: 27018785.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    21. Re: Jan P. Radtke, Constantin Schwab, Maya B. Wolf, et al. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.12.052. Eur Urol. 2016 09; 70(3):e77-8. Williams SB, Ward JF. PMID: 26988610.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. The feasibility and safety of repeat cryosurgical ablation of localized prostate cancer. World J Surg Oncol. 2015 Dec 21; 13:340. Mustafa M, Delacroix S, Ward JF, Pisters L. PMID: 26691335.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Active surveillance monitoring: the role of novel biomarkers and imaging. Asian J Androl. 2015 Nov-Dec; 17(6):882-4; discussion 883. Ward JF, Eggener SE. PMID: 26112488.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System. Clin Genitourin Cancer. 2016 Apr; 14(2):130-8. Williams SB, Davis JW, Wang X, Achim MF, Zurita-Saavedra A, Matin SF, Pisters LL, Ward JF, Pettaway CA, Chapin BF. PMID: 26558524.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design. Urol Oncol. 2015 Nov; 33(11):495.e1-7. van den Bos W, Muller BG, de Bruin DM, de Castro Abreu AL, Chaussy C, Coleman JA, Finelli A, Gill IS, Gross ME, Jenniskens SF, Kahmann F, Laguna-Pes MP, Rastinehad AR, Simmons LA, Sulser T, Villers A, Ward JF, de la Rosette JJ. PMID: 26231310.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int. 2016 07; 118(1):68-76. Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim J. PMID: 26059275.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    27. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int. 2016 Mar; 117(3):469-77. Parker PA, Davis JW, Latini DM, Baum G, Wang X, Ward JF, Kuban D, Frank SJ, Lee AK, Logothetis CJ, Kim J. PMID: 25714186.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    28. Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRß/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial. J Hematol Oncol. 2014 Aug 01; 7:52. Subbiah V, Meric-Bernstam F, Mills GB, Shaw KR, Bailey AM, Rao P, Ward JF, Pagliaro LC. PMID: 25085632.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    29. Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic. J Natl Compr Canc Netw. 2014 Jul; 12(7):993-8. Madsen LT, Kuban DA, Choi S, Davis JW, Kim J, Lee AK, Domain D, Levy L, Pisters LL, Pettaway CA, Ward JF, Logothetis C, Hoffman KE. PMID: 24994920.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Health technology assessment in evolution - focal therapy in localised prostate cancer. Expert Rev Anticancer Ther. 2014 Nov; 14(11):1359-67. Valerio M, Emberton M, Barret E, Eberli D, Eggener SE, Ehdaie B, Jichlinski P, Ward JF, Ahmed HU. PMID: 24965212.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. Supporting prostate cancer focal therapy: a multidisciplinary International Consensus of Experts ("ICE"). Aging Male. 2014 Jun; 17(2):66-71. Reis LO, Billis A, Zequi SC, Tobias-Machado M, Viana P, Cerqueira M, Ward JF. PMID: 24597940.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    32. Cryoablation for locally advanced clinical stage T3 prostate cancer: a report from the Cryo-On-Line Database (COLD) Registry. BJU Int. 2014 May; 113(5):714-8. Ward JF, DiBlasio CJ, Williams C, Given R, Jones JS. PMID: 24112776.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Focal therapy in prostate cancer: international multidisciplinary consensus on trial design. Eur Urol. 2014 Jun; 65(6):1078-83. van den Bos W, Muller BG, Ahmed H, Bangma CH, Barret E, Crouzet S, Eggener SE, Gill IS, Joniau S, Kovacs G, Pahernik S, de la Rosette JJ, Rouvière O, Salomon G, Ward JF, Scardino PT. PMID: 24444476.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    34. Considerations for patient selection for focal therapy. Ther Adv Urol. 2013 Dec; 5(6):330-7. Ward JF, Pisters LL. PMID: 24294291.
      View in: PubMed   Mentions:
    35. Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma. BJU Int. 2013 Jun; 111(7):1068-74. Matin SF, Cormier JN, Ward JF, Pisters LL, Wood CG, Dinney CP, Royal RE, Huang X, Pettaway CA. PMID: 23551693.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    36. PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study. J Urol. 2013 Jul; 190(1):64-9. Gittelman MC, Hertzman B, Bailen J, Williams T, Koziol I, Henderson RJ, Efros M, Bidair M, Ward JF. PMID: 23416644.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    37. Pathological characteristics of prostate cancer recurrence after radiation therapy: implications for focal salvage therapy. J Urol. 2012 Jul; 188(1):98-102. Leibovici D, Chiong E, Pisters LL, Guo CC, Ward JF, Andino L, Prokhorova IN, Troncoso P. PMID: 22578724.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    38. Focal therapy for the treatment of localized prostate cancer: a potential therapeutic paradigm shift awaiting better imaging. Curr Opin Urol. 2012 Mar; 22(2):104-8. Ward JF, Rewcastle JC, Ukimura O, Gill IS. PMID: 22273756.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. Is transureteroureterostomy performed during multi-organ resection for non-urothelial malignancy safe and effective? J Surg Oncol. 2012 Jul 01; 106(1):62-5. Pisters PW, Pettaway CA, Liu P, Matin SF, Ward JF, Leibovici D. PMID: 22259198.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Comparative effectiveness, cost, and utilization of radical prostatectomy among young men within managed care insurance plans. Value Health. 2012 Mar-Apr; 15(2):367-75. Shih YC, Ward JF, Pettaway CA, Xu Y, Matin SF, Davis JW, Thompson BP, Elting LS. PMID: 22433769.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int. 2012 Jun; 109(11):1648-54. Ward JF, Jones JS. PMID: 22035200.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    42. Multiple kinase pathways involved in the different de novo sensitivity of pancreatic cancer cell lines to 17-AAG. J Surg Res. 2012 Jul; 176(1):147-53. Liu H, Zhang T, Chen R, McConkey DJ, Ward JF, Curley SA. PMID: 22099584.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    43. Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry. BJU Int. 2011 Aug; 108(4):508-12. Dhar N, Ward JF, Cher ML, Jones JS. PMID: 21722288.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    44. High-intensity focused ultrasound for therapeutic tissue ablation in surgical oncology. Surg Oncol Clin N Am. 2011 Apr; 20(2):389-407, ix. Ward JF. PMID: 21377590.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry. BJU Int. 2011 Oct; 108(8 Pt 2):E196-201. Ganzer R, Robertson CN, Ward JF, Brown SC, Conti GN, Murat FJ, Pasticier G, Rebillard X, Thuroff S, Wieland WF, Blana A. PMID: 21332907.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    46. Prostate cancer: HIFU is effective, but associated morbidity still remains unclear. Nat Rev Urol. 2010 Nov; 7(11):597-8. Ward JF. PMID: 21068758.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging. Eur Urol. 2011 Jan; 59(1):96-105. Auprich M, Chun FK, Ward JF, Pummer K, Babaian R, Augustin H, Luger F, Gutschi S, Budäus L, Fisch M, Huland H, Graefen M, Haese A. PMID: 20980098.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    48. Magnetic resonance guided, focal laser induced interstitial thermal therapy in a canine prostate model. J Urol. 2010 Oct; 184(4):1514-20. Stafford RJ, Shetty A, Elliott AM, Klumpp SA, McNichols RJ, Gowda A, Hazle JD, Ward JF. PMID: 20727549.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    49. Contemporary outcomes of focal therapy in prostate cancer: what do we know so far... World J Urol. 2010 Oct; 28(5):593-7. Ward JF. PMID: 20680294.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Classification system: organ preserving treatment for prostate cancer. Urology. 2010 Jun; 75(6):1258-60. Ward JF, Jones JS. PMID: 20080292.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    51. Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour foci. BJU Int. 2010 May; 105(10):1386-91. Davis JW, Kim J, Ward JF, Wang X, Nakanishi H, Babaian RJ, Troncoso P. PMID: 19888979.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    52. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol. 2009 Aug; 182(2):517-25; discussion 525-7. Pisters LL, Leibovici D, Blute M, Zincke H, Sebo TJ, Slezak JM, Izawa J, Ward JF, Scott SM, Madsen L, Spiess PE, Leibovich BC. PMID: 19524984.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    53. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure. BJU Int. 2009 Oct; 104(8):1058-62. Blana A, Brown SC, Chaussy C, Conti GN, Eastham JA, Ganzer R, Murat FJ, Pasticier G, Rebillard X, Rewcastle JC, Robertson CN, Thuroff S, Ward JF. PMID: 19388986.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    54. Editorial comment on: Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy. Eur Urol. 2010 Mar; 57(3):444-5. Ward JF. PMID: 19303198.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    55. Continous improvement of TNM staging system for bladder cancer. Cancer. 2009 Feb 15; 115(4):704-5. Ward JF, Margulis V. PMID: 19117038.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy. BJU Int. 2009 Aug; 104(4):490-7. Ward JF, Nakanishi H, Pisters L, Babaian RJ, Troncoso P. PMID: 19220260.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    57. Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues. Proc Natl Acad Sci U S A. 2009 Feb 24; 106(8):2729-34. Chen H, Liakou CI, Kamat A, Pettaway C, Ward JF, Tang DN, Sun J, Jungbluth AA, Troncoso P, Logothetis C, Sharma P. PMID: 19202079.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    58. Salvage therapy for radiorecurrent prostate cancer. Curr Probl Cancer. 2008 Nov-Dec; 32(6):242-71. Ward JF, Pagliaro LC, Pisters LL. PMID: 19064119.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    59. Management of the patient with a rising PSA alone. Hematol Oncol Clin North Am. 2006 Aug; 20(4):897-908. Moul JW, Ward JF. PMID: 16861121.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. Can PSA velocity serve as a surrogate endpoint in trials of hormone-refractory, metastatic prostate cancer? Nat Clin Pract Urol. 2006 Jun; 3(6):310-1. Ward JF. PMID: 16763642.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. Comments on "single-strand-specific radiosensitization by bromodeoxyuridine" by Cecchini et Al. Radiat Res. 2005 Sep; 164(3):341-2; author reply 342-3. Ward JF. PMID: 16137210.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    62. Treating the biochemical recurrence of prostate cancer after definitive primary therapy. Clin Prostate Cancer. 2005 Jun; 4(1):38-44. Ward JF, Moul JW. PMID: 15992460.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    63. Biochemical recurrence after definitive prostate cancer therapy. Part I: defining and localizing biochemical recurrence of prostate cancer. Curr Opin Urol. 2005 May; 15(3):181-6. Ward JF, Moul JW. PMID: 15815195.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    64. Biochemical recurrence after definitive prostate cancer therapy. Part II: treatment strategies for biochemical recurrence of prostate cancer. Curr Opin Urol. 2005 May; 15(3):187-95. Ward JF, Moul JW. PMID: 15815196.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    65. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol. 2005 Apr; 173(4):1156-60. Ward JF, Sebo TJ, Blute ML, Zincke H. PMID: 15758726.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    66. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int. 2005 Apr; 95(6):751-6. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. PMID: 15794776.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    67. Rising prostate-specific antigen after primary prostate cancer therapy. Nat Clin Pract Urol. 2005 Apr; 2(4):174-82. Ward JF, Moul JW. PMID: 16474760.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    68. Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy. J Urol. 2004 Dec; 172(6 Pt 1):2244-8. Ward JF, Zincke H, Bergstralh EJ, Slezak JM, Blute ML. PMID: 15538240.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    69. The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy. J Urol. 2004 Oct; 172(4 Pt 1):1328-32. Ward JF, Zincke H, Bergstralh EJ, Slezak JM, Myers RP, Blute ML. PMID: 15371834.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    70. Repair of oxidative guanine damage in plasmid DNA by indoles involves proton transfer between complementary bases. Biochemistry. 2004 Jul 20; 43(28):9098-104. Ly A, Tran NQ, Ward JF, Milligan JR. PMID: 15248767.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    71. Use and timing of radiotherapy in high-risk prostate cancer. JAMA. 2004 Jun 16; 291(23):2817; author reply 2817-8. Ward JF, Blute ML. PMID: 15199027.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    72. Peptide repair of oxidative DNA damage. Biochemistry. 2004 May 04; 43(17):5102-8. Milligan JR, Tran NQ, Ly A, Ward JF. PMID: 15109269.
      View in: PubMed   Mentions: 5     Fields:    Translation:Cells
    73. The effects of dietary factors on the androgen receptor and related cellular factors in prostate cancer. Curr Med Chem. 2004 Apr; 11(7):909-23. Young CY, Jatoi A, Ward JF, Blute ML. PMID: 15078173.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    74. Repair of guanyl radicals in plasmid DNA by electron transfer is coupled to proton transfer. J Am Chem Soc. 2004 Feb 18; 126(6):1682-7. Milligan JR, Aguilera JA, Hoang O, Ly A, Tran NQ, Ward JF. PMID: 14871098.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    75. Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance? Urol Oncol. 2004 Jan-Feb; 22(1):40-7. Ward JF, Bartsch G, Sebo TJ, Pinggera GM, Blute ML, Zincke H. PMID: 14969803.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    76. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol. 2003 Nov; 170(5):1872-6. Ward JF, Blute ML, Slezak J, Bergstralh EJ, Zincke H. PMID: 14532796.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    77. Radiation-dependent limit for the viability of bacterial spores in halite fluid inclusions and on Mars. Radiat Res. 2003 Jun; 159(6):722-9. Kminek G, Bada JL, Pogliano K, Ward JF. PMID: 12751954.
      View in: PubMed   Mentions: 8     Fields:    Translation:Cells
    78. Radical prostatectomy for the patient with locally advanced prostate cancer. Curr Urol Rep. 2003 Jun; 4(3):196-204. Ward JF, Zincke H. PMID: 12756082.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    79. Chemoprevention of prostate cancer. Expert Rev Anticancer Ther. 2003 Apr; 3(2):203-14. Ward JF, Blute ML. PMID: 12722880.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J Urol. 2002 Dec; 168(6):2457-60. Gray Sears CL, Ward JF, Sears ST, Puckett MF, Kane CJ, Amling CL. PMID: 12441939.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    81. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. J Urol. 2002 Jul; 168(1):56-60. Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. PMID: 12050492.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    82. Multi-institutional experience with buccal mucosa onlay urethroplasty for bulbar urethral reconstruction. J Urol. 2002 Mar; 167(3):1314-7. Kane CJ, Tarman GJ, Summerton DJ, Buchmann CE, Ward JF, O'Reilly KJ, Ruiz H, Thrasher JB, Zorn B, Smith C, Morey AF. PMID: 11832721.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    83. The radiation-induced lesions which trigger the bystander effect. Mutat Res. 2002 Feb 20; 499(2):151-4. Ward JF. PMID: 11827708.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    John's Networks
    Concepts (283)
    Derived automatically from this person's publications.
    Co-Authors (14)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department